A Michigan federal judge on Sunday certified a class of investors accusing Esperion Therapeutics Inc. of falsely stating that the U.S. Food and Drug Administration wouldn't be requiring a time-consuming study before approving a new cholesterol drug, finding that the claims lend themselves well to a class action.
A drug distributor and two executives indicted for allegedly conspiring to flood Appalachia with opioids are brazenly arguing they had "carte blanche" to sell highly addictive painkillers without a legitimate medical need, the U.S. Department of Justice told an Ohio federal court Monday.
A Boston federal judge has refused to release a pharmacist connected to a deadly meningitis outbreak from prison on compassionate-release grounds related to the spread of the novel coronavirus inside prisons, saying there's nothing "extraordinary" about the man's situation.
Rhode Island's high court on Friday affirmed a decision finding that W.B. Mason did not violate employment laws when managers asked a supply driver who used medical marijuana to undergo a drug test and fired him after he refused.
The U.S. Environmental Protection Agency on Monday reduced how much of the carcinogenic chemical ethylene oxide that some chemical manufacturers can release, targeting a pollutant that has increasingly been the subject of lawsuits.
The Trump administration moved to toss a class action challenge to a proclamation targeting uninsured green card seekers, telling an Oregon federal judge that the visa applicants don't have upcoming consular interviews and it was unlikely the policy would imminently affect them.
As Johnson & Johnson promises to keep fighting the legal war over allegations that its recently discontinued talc-based baby powder causes cancer, experts say the history of asbestos litigation shows the company can expect that war to last decades.
A Massachusetts appeals court on Monday revived a suit accusing Tufts Medical Center and others of causing a patient's infection death from contaminated medication, saying there is a factual dispute as to whether a doctor inspected the drug packaging for cracks.
Bausch Health Cos. Inc. and its brass on Friday sought to shed a securities fraud lawsuit that alleges the company engaged in a price-gouging scheme that cost investors billions, telling a New Jersey federal judge that investors' claims came too late.
In this edition of Coronavirus Q&A, a Cohen Milstein Sellers & Toll PLLC partner representing people who have suffered catastrophic injuries, who also serves as an advocate for trial attorneys, discusses how the COVID-19 pandemic has affected client intake and lobbying efforts.
A New Jersey federal judge on Sunday handed wins to six insurers, finding they are not obligated to reimburse prescription drug benefit administrator Benecard Services Inc. for its settlement of a $75 million suit over its alleged mismanagement of Medicare Part D plans.
An unsolicited fax to a doctor's office offering a free webinar was not an "advertisement" in violation of the Telephone Consumer Protection Act since there was nothing being sold, a Pennsylvania federal judge has ruled.
Private equity firm Avista Capital Partners said Monday it will acquire European health care company Vision Healthcare alongside co-investor VHC Investco in a deal steered by Ropes & Gray LLP and Allen & Overy LLP that values Vision Healthcare at €305 million (about $336 million).
Perkins Coie LLP added an experienced attorney to its corporate and securities practice from K&L Gates LLP in Dallas last week, adding to its expanding Texas operations.
The Treasury Department and federally recognized tribes have asked a D.C. federal judge for quick wins in the tribes' suits against the government seeking to block Alaska Native corporations from receiving millions of dollars in federal COVID-19 relief, battling over whether the companies qualify for the funds under the CARES Act.
The Florida-based company that runs The Lasik Vision Institute and TLC Laser Eye Centers filed for Chapter 11 protection in Delaware, saying the coronavirus pandemic shutdown on nonessential medical services exacerbated an already-existing liquidity crunch and forced the company into bankruptcy.
A Tennessee appeals court on Thursday approved the reduction of a $4.5 million medical malpractice award to $1.25 million in a closely watched case that had included a constitutional challenge to the state's statutory damages cap.
Democratic lawmakers called on the U.S. Department of Defense to detail how it is spending $10.6 billion in taxpayer dollars provided for efforts to combat the spread of COVID-19 and questioned why only 23% of the funds had been spent so far.
A prominent New Jersey psychologist whose license was suspended after he disclosed sensitive patient information to debt collection attorneys is stuck with more than $100,000 in sanctions after a state appellate court found his violations were egregious.
A Louisiana bill expanding the list of conditions that qualify patients for medical marijuana and a Missouri bill placing stricter regulations on edible products advanced through their respective statehouses this week. Here, Law360 takes stock of some of the legislative developments in cannabis at the state and federal level.
The novel coronavirus pandemic has continued to cause delays and waivers in the patent and trademark worlds, and also has led to questions about who owns the rights to a key antiviral drug and whether Zoom should be concerned about its trademark.
Adventist Health System says a California attorney and a company that failed to deliver on a $57.5 million deal for 10 million N95 masks have refused to return $2 million in escrow funds even though the deal fell apart, according to a suit filed Friday in Florida.
Florida has told the state's high court that a medical pot dispensary is not likely to succeed in its claims that Florida's licensing system law for dispensaries amounted to an unconstitutional "special law," saying the statute is reasonable and rational.
President Donald Trump said Friday he is terminating the United States' relationship with the World Health Organization over its failure to enact reforms after fumbling the COVID-19 health crisis and announced a series of aggressive actions against China.
The Fifth Circuit has affirmed a lower court's nixing of a $61.8 million False Claims Act suit alleging Baylor Scott & White Health overbilled Medicare over seven years, ruling Thursday that the relator's own complaint indicates that the health care system's practices were simply ahead of the curve.
The current decrease in formality and increase in common ground due to the work-from-home environment can make it easier to have a networking conversation, says Megan Burke Roudebush at Keepwith.
The Federal Trade Commission's notification rule for nonhealth companies that suffer health record data breaches is too narrow, and should be replaced by a federal privacy law that provides uniform and meaningful protections for consumers, says Dena Castricone at DMC Law.
One mistake that attorneys commonly make when presenting a case to a third-party funder is focusing almost exclusively on liability and giving short shrift to the damages analysis — resulting in an aspirational damages estimate that falls apart under scrutiny, say Cindy Ahn and Justin Maleson at Longford Capital and Casey Grabenstein at Saul Ewing.
Companies that bid on projects financed wholly or in part by multilateral development banks to combat the crises caused by the pandemic must have appropriate anti-corruption mechanisms in place to limit the risks of sanctions investigations several years down the road, say Lauren Muldoon and Spencer Bruck at Orrick.
Attorneys at WilmerHale highlight recent developments in privilege law, the significant challenges raised by nontraditional working arrangements popularized during the pandemic, and ways to avoid waiving attorney-client privilege when using electronic communications.
A provision in the CARES Act that overhauls the over-the-counter drug monograph system should be a welcome development for certain drug manufacturers and developers but may also result in increased federal scrutiny and enforcement activity, say attorneys at Ropes & Gray.
To properly manage outside counsel, it's imperative for a company's legal department to implement and maintain rules on what they will and won't pay for, on staffing cases and requesting rate increases, and on how matters will be handled, says Chris Seezen at Quovant.
Indirect purchasers are accusing AbbVie of anti-competitive conduct through the use of so-called patent thickets to allegedly delay biosimilar versions of Humira — a theory that would potentially hold a pharmaceutical company liable for the acquisition and enforcement of its patents, raising important legal and economic questions, say analysts at Charles River Associates.
The Centers for Medicare & Medicaid Services' proposed rule establishing penalties for Medicare secondary payer late reporting unduly punishes entities for making good faith efforts to disclose claims, says Re Knack at the Medicare Advocacy Recovery Coalition.
As the economy reopens, sports leagues planning to bring back games with fans in attendance will need to weigh not only important health and safety issues but also the accompanying business and legal risks, say Christopher Conniff and Nicholas Macri at Ropes & Gray.
While pulling off an effective summer associate program this year will be no easy feat, law firms' investments in their future attorneys should be considered necessary even during this difficult time, says Summer Eberhard at Major Lindsey.
As the COVID-19 pandemic complicates the valuation of companies involved in mergers and acquisitions, targets and acquirers alike should take several prudent preclosing steps to mitigate the risk of deal-breaking disputes and subsequent litigation, say Ann Gittleman and Jenna O'Brien at Duff & Phelps.
Attorneys at WilmerHale analyze Securities Act complaints against companies that went public immediately prior to and during the COVID-19-induced market volatility, providing preliminary insights into whether, when and on what basis recent issuers are facing securities litigation.
Employers should use extra caution to sidestep several key wage and hour mistakes as businesses prepare to reopen following the coronavirus crisis and worker classification and Fair Labor Standards Act compliance comes under increased scrutiny, say Kathleen Caminiti and Eric Baginski at Fisher Phillips.
While Latin American governments respond to pandemic-related financial needs, multinational companies face elevated compliance risks from increased interaction with government officials, and new enforcement policies related to the misappropriation of funds, expedited government contracting, increased transparency and monitoring, and international cooperation, say attorneys at K&L Gates.